Skip to main content
Harsha Mirchandani headshot

Harsha Mirchandani

FSA, MAAA
Senior Consulting Actuary
New York, NY, US

Harsha Mirchandani is a senior consulting actuary with the New York office of Milliman. She joined the firm in 2016.

Download bioDownload

Experience

Harsha has provided consulting services to a broad range of clients, including health plans, provider groups, hospital systems, pharmaceutical companies, and other healthcare providers.

Harsha has extensive experience with the following:

  • Harsha has extensive experience with the following:
  • Alternative payment model design, implementation, and reconciliation
  • Value-based contracting design and analytics
  • Claims-based analytics and benchmarking
  • Advanced data visualization using business intelligence software (e.g., PowerBI, Qlik)

Prior to joining Milliman, Harsha worked in pharmaceutical and medical device marketing.

Publications

Read their latest work

Article

6 issues Milliman is watching for health systems and provider organizations in 2026

08 January 2026 - by Rebecca Smith, Harsha Mirchandani
Learn about the key issues healthcare providers and health systems should be watching in 2026
Article

The continued evolution of CMS’s mandatory models: The Ambulatory Specialty Model (ASM)

20 November 2025 - by Noah Champagne, Harsha Mirchandani, Danielle Rubin
We detail characteristics and impact of the Ambulatory Specialty Model, a framework proposed by the Centers for Medicare and Medicaid Services.
Article

Understanding nonfatal firearm injuries: Incidence and healthcare spending for commercially insured members

23 October 2025 - by Charmaine Girdish, Harsha Mirchandani, Allison Halpren, Rebecca L. Johnson
Patient healthcare costs increase substantially in the six months after a nonfatal firearm injury. We analyze patterns for stakeholders to consider.
Article

6 considerations for developing an oncology payment model

07 July 2025 - by Harsha Mirchandani
We offer life sciences companies six things to consider when developing an oncology payment model, from defining the population to ensuring high-quality care.
Article

Methodology review of Stork Club’s assisted reproductive technology performance measure comparison study

15 March 2024 - by Harsha Mirchandani, Brittany Ryan, Carol Bazell
We examine Stork Club’s methodology for assessing Assisted Reproductive Technology performance measures.
Article

Summary of The U.S. Playbook to Address Social Determinants of Health

11 December 2023 - by Bridget Darby, Harsha Mirchandani, Shelley Moss
We summarize of the pillars contained in the White House’s "U.S. Playbook to Address Social Determinants of Health" and discuss implications for stakeholders.
Article

Treatment patterns for generalized anxiety disorder and insomnia in Medicare fee-for-service

28 March 2023 - by Carol Bazell, Harsha Mirchandani, Pamela M. Pelizzari, Katherine Brinkers
Insomnia and generalized anxiety disorder are common mental health conditions in the Medicare population.
Article

Enhancing Oncology Model (EOM): OCM “2.0”

28 July 2022 - by Harsha Mirchandani, Noah Champagne, Pamela M. Pelizzari
This article highlights considerations for providers interested in voluntary enhanced oncology model, which builds on concepts of a recently completed CMMI model designed to transform oncology care while reducing spending under Medicare fee-for-service.
Article

Strategy considerations for effectively entering the Medicare Advantage market

14 July 2022 - by Eric A. Buzby, Harsha Mirchandani, Jared Hirsch
Six important topics insurers should consider as they contemplate entering the Medicare Advantage market.
Article

Healthcare cost journey for survivors of firearm injuries

11 July 2022 - by Samantha Tomicki, Harsha Mirchandani, Rebecca L. Johnson
Given the medical costs of nonfatal firearm injuries, healthcare stakeholders have an interest in supporting further research to mitigate firearm injury risk